SBIR/STTR Research Award

Computational framework for analysis of microarray gene expression data

Award identifier f6680a1a44fccd2d92c38355e2035ce3b05ba0ff4a9b1e7053f7be82fd76c17fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$299,983

Program and phase

SBIR · Phase I

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOFORMATIX, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2009-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Identification of transcripts that are differentially regulated in response to studied experimental conditions is one of critical steps in analysis of DNA microarray data. Currently employed statistical approaches become particularly ineffective for experiments with small number of biological replicates, which are prevalent in the differential expression studies. We propose to develop and validate a novel numerical framework for identification of differentially expressed transcripts, with emphasis on analysis of experiments with small number of replicates and genes with moderate levels of expression. The proposed approach is based on a novel, non-parametric method for assessment of noise distributions in microarray data, which are derived directly from the analyzed data set. Three distinct, univariate and multivariate methods for identification of differentially expressed genes will be implemented and their results will be compared to the results of leading advanced statistical methods. In the Phase I feasibility study we will analyze differential gene expression between at least nine normal tissues with varying levels of similarity, in rat and mouse. Publicly available data from SymAtlas database (Genomics Institute of the Novartis Research Foundation), obtained with Affymetrix microarrays, will be employed. The utility of newly developed numerical methods will be established through biological and/or experimental validation of identified genomic biomarkers using functional analysis (if functional annotation is available) and/or quantitative polymerase chain reaction analysis. PUBLIC HEALTH RELEVANCE: DNA microarray technology enables simultaneous profiling of thousands of transcripts expressed in particular organism, cells or tissues. Its current applications include gene profiling, gene regulation studies, disease biomarker discovery, toxicogenomics, pharmacogenomics, and clinical diagnostics and prognosis. Despite recent impressive technological advances, major bottlenecks to the realization of the full potential of the microarray technology exist and include incomplete functional gene annotation and the lack of effective computational data analysis tools. The analysis methods developed in this project will improve the ability to reliably identify differentially expressed genes in experiments with small number of biological replicates, which will improve the overall effectiveness of this technology and reduce the cost of microarray gene expression studies.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.